IHC-plus(tm) SCN5A / Nav1.5 Antibody (aa1548-1558)

LifeSpan BioSciences

IHC-plus(tm) SCN5A / Nav1.5 Antibody (aa1548-1558)

23

Human SCN5A / Nav1.5. This antibody is expected to recognise all reported isoforms (NP_932173.1; NP_000326.2; NP_001092874.1; NP_001092875.1).

Immunohistochemistry: LS-B8 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B8 was determined to be 5-10 ug/ml.. IHC, IHC-P (5 - 10 µg/ml), Peptide-ELISA (1:32000) Immunohistochemistry: LS-B8 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B8 was determined to be 5-10 ug/ml.

ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.5 mg/ml

Unconjugated

...

SCN5A

sodium voltage-gated channel alpha subunit 5

cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit; CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; sodium channel protein cardiac muscle subunit alpha; sodium channel protein type 5 subunit alpha; sodium channel, voltage-gated, type V, alpha subunit; SSS1; VF1; voltage-gated sodium channel subunit alpha Nav1.5

Goat

Human

-20°C

12352203